# US 2021/0062220 A1 · Methods and constructs for production of lentiviral vector

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0062220 A1
- Document ID: US20210062220A1
- Status: Published application
- Kind: A1
- Application number: 17/001,114
- Filed: 2020-08-24
- Published: 2021-03-04
- Earliest claimed: 2019-08-23
- Assignees: Lonza Walkersville, Inc.
- Applicants: Lonza Walkersville, Inc.
- Inventors: Young SHIN; Anandita SETH; Bingnan GU
- Web page: https://patentgrep.com/patent/US20210062220A1

## CPC

- C12N 15/867: Retroviral vectors
- C07K 14/161: {gag-pol, e.g. p55, p24/25, p17/18, p7, p6, p66/68, p51/52, p31/34, p32, p40}
- C07K 14/162: {env, e.g. gp160, gp110/120, gp41, V3, peptid T, CD4-Binding site}
- C07K 14/163: {Regulatory proteins, e.g. tat, nef, rev, vif, vpu, vpr, vpt, vpx}
- C12N 5/0686: {Kidney cells}
- C12N 9/1241: {Nucleotidyltransferases (2.7.7)}
- C12N 15/8673: {Special methods for packaging systems}
- C12N 15/8676: {Special methods for targeting systems}
- C12N 15/86: Viral vectors
- C12N 2740/15051: Methods of production or purification of viral material
- C12N 2740/16052: relating to complementing cells and packaging systems for producing virus or viral particles
- C12N 2760/20222: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present disclosure relates to methods for producing lentiviral vector-producing cells. Specifically the methods utilize two plasmids, rather than four, to provide the required packaging elements and transfer vector to a cell, allowing for the production of a large number of lentiviral producer cells, including suspension-based cells, and the production of high amounts of lentivirus. These methods allow for the production of cells that can be later induced to produce lentivirus, and can be tailored to include a specific gene of interest.

## Claims

### Claim 1

A method of producing a lentiviral packaging vector-containing mammalian cell, comprising:
a. transfecting a mammalian cell with:
i. a packaging vector including an expression cassette, encoding:
1. a lentiviral regulator of expression of virion proteins (REV) gene under control of a first promoter;
2. a lentiviral envelope gene under control of a second promoter; and
3. a lentiviral group specific antigen (GAG) gene and a lentiviral polymerase (POL) gene both under control of a third promoter,
wherein the expression cassette is flanked on both the 5′ and 3′ ends by transposon-specific inverted terminal repeats (ITR); and
b. culturing the transfected mammalian cell; and
c. isolating the lentiviral packaging vector-containing mammalian cell.

### Claim 2 (depends on 1)

The method of claim 1, wherein the mammalian cell is a mammalian cell culture.

### Claim 3 (depends on 2)

The method of claim 2, wherein the mammalian cell culture is a suspension culture.

### Claim 4 (depends on 3)

The method of claim 3, wherein the mammalian cell is an HEK293T cell.

### Claim 5 (depends on 1)

The method of claim 1, wherein the GAG gene is an HIV GAG gene and the POL gene is an HIV POL gene.

### Claim 6 (depends on 1)

The method of claim 1, wherein the lentiviral envelope gene is a Vesicular Stomatitis Virus Glycoprotein (VSV-G) gene.

### Claim 7 (depends on 1)

The method of claim 1, wherein the first, second and third promoters are derepressible promoters.

### Claim 8 (depends on 7)

The method of claim 7, wherein the expression cassette further encodes a repressor element of the first, second and third derepressible promoters

### Claim 9 (depends on 8)

The method of claim 8, wherein each of the derepressible promoters comprises a functional promoter and a tetracycline operator sequence (TetO), and the repressor element is a tetracycline repressor protein.

### Claim 10 (depends on 9)

The method of claim 9, wherein the expression cassette further comprises a Kruppel-associated box sequence following a sequence encoding the tetracycline repressor protein.

### Claim 11 (depends on 1)

The method of claim 1, wherein the transposon-specific ITRs are Lepidopteran transposon (PIGGYBAC®) ITRs.

### Claim 12 (depends on 1)

The method of claim 1, wherein the transfecting is in the presence of a transposase that recognizes the transposon-specific ITRs.

### Claim 13 (depends on 12)

The method of claim 12, wherein the transposase is Lepidopteran (PIGGYBAC®) transposase mRNA or Lepidopteran (PIGGYBAC®) transpose cDNA.

### Claim 14

A method of producing a lentiviral vector-producing mammalian cell, comprising:
a. transfecting a mammalian cell with:
i. a packaging vector including an expression cassette, encoding:
1. a lentiviral regulator of expression of virion proteins (REV) gene under control of a first promoter;
2. a lentiviral envelope gene under control of a second promoter; and
3. a lentiviral group specific antigen (GAG) gene and a lentiviral polymerase (POL) gene both under control of a third promoter,
wherein the expression cassette is flanked on both the 5′ and 3′ ends by transposon-specific inverted terminal repeats (ITR); and
ii. a transfer vector, comprising:
1. a nucleic acid sequence encoding a gene of interest under control of a fourth promoter,
wherein the nucleic acid sequence is flanked on both the 5′ and 3′ ends by transposon-specific inverted terminal repeats (ITR);
b. culturing the transfected mammalian cell; and
c. isolating the lentiviral vector-producing mammalian cell.

### Claim at position 15

15-33. (canceled)

### Claim 34

A mammalian cell for producing a lentiviral vector, comprising:
a. a nucleic acid molecule chromosomally integrated into the mammalian cell, the nucleic acid molecule comprising
i. a lentiviral regulator of expression of virion proteins (REV) gene under control of a first promoter;
ii. a lentiviral envelope gene under control of a second promoter; and
iii. a lentiviral group specific antigen (GAG) gene and a lentiviral polymerase (POL) gene both under control of a third promoter,
wherein the nucleic acid sequence is flanked on both the 5′ and 3′ ends by sequences resulting from the recombination of transposon-specific inverted terminal repeats (ITRs).

### Claim 35 (depends on 34)

The mammalian cell of claim 34, further comprising a chromosomally integrated nucleic acid sequence encoding a gene of interest under control of a fourth promoter.

### Claim at position 18

36-46. (canceled)

### Claim 47 (depends on 34)

A method of producing a lentiviral vector, comprising:
a. transfecting the mammalian cell of claim 34 with a transfer vector, comprising:
i. a nucleic acid sequence encoding a gene of interest under control of a fourth promoter;
b. inducing production of the expression cassette and the nucleic acid;
c. culturing the transfected mammalian cell; and
d. harvesting the lentiviral vector.

### Claim 48 (depends on 35)

A method of producing a lentiviral vector, comprising:
a. inducing production of the chromosomally integrated nucleic acid sequence and the chromosomally integrated nucleic acid sequence encoding a gene of interest of the mammalian of claim 35;
b. culturing the mammalian cell; and
c. harvesting the lentiviral vector.

### Claim at position 21

49-54. (canceled)
